527
Views
39
CrossRef citations to date
0
Altmetric
Review

Influence of diabetes mellitus on anterior segment of the eye

, &
Pages 53-63 | Published online: 27 Dec 2018

References

  • AlbertiKGZimmetPZDefinitionZPZDefinition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultationDiabet Med19981575395539686693
  • ShihKCLamKSTongLA systematic review on the impact of diabetes mellitus on the ocular surfaceNutr Diabetes201773e25128319106
  • MarkoulliMFlanaganJTummanapalliSSWuJWillcoxMThe impact of diabetes on corneal nerve morphology and ocular surface integrityOcul Surf2018161455729113918
  • NohJThe diabetes epidemic in KoreaEndocrinol Metab (Seoul)201631334935327586447
  • AbdelkaderHPatelDVMcGheeCNJAlanyRGNew therapeutic approaches in the treatment of diabetic keratopathy: a reviewClin Exp Ophthalmol201139325927020973888
  • Vieira-PotterVJKaramichosDLeeDJOcular complications of diabetes and therapeutic approachesBioMed Res Int201620163114
  • PritchardNEdwardsKRussellAWCorneal confocal microscopy predicts 4-year incident peripheral neuropathy in type 1 diabetesDiabetes Care2015384671525573881
  • DogruMKatakamiCInoueMTear function and ocular surface changes in noninsulin-dependent diabetes mellitusOphthalmology2001108358659211237914
  • YoonKCImSKSeoMSChanges of tear film and ocular surface in diabetes mellitusKorean J Ophthalmol200418216817415635831
  • O’DonnellCEfronNDiabetes and contact lens wearClin Exp Optom201295332833722537249
  • PritchardNEdwardsKShahidiAMCorneal markers of diabetic neuropathyOcul Surf201191172821338566
  • BikbovaGOshitariTBabaTDiabetic corneal neuropathy: clinical perspectivesClin Ophthalmol20181298198729872257
  • SmithHSArgoffCEPharmacological treatment of diabetic neuropathic painDrugs201171555758921443281
  • PirartJDiabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (3rd and last part)Diabete Metab197734245256 French598565
  • NowotnyKJungTHöhnAWeberDGruneTAdvanced glycation end products and oxidative stress in type 2 diabetes mellitusBiomolecules20155119422225786107
  • YagihashiSMizukamiHSugimotoKMechanism of diabetic neuropathy: where are we now and where to go?J Diabetes Investig2011211832
  • BabizhayevMAStrokovIANosikovVVThe role of oxidative stress in diabetic neuropathy: generation of free radical species in the glycation reaction and gene polymorphisms encoding antioxidant enzymes to genetic susceptibility to diabetic neuropathy in population of type I diabetic patientsCell Biochem Biophys20157131425144325427889
  • TomlinsonDRFernyhoughPDiemelLTRole of neurotrophins in diabetic neuropathy and treatment with nerve growth factorsDiabetes199746Suppl 2S43S499285498
  • KimJKimCSSohnEJeongIHKimHKimJSInvolvement of advanced glycation end products, oxidative stress and nuclear factor-kappaB in the development of diabetic keratopathyGraefes Arch Clin Exp Ophthalmol2011249452953621104267
  • AubertCEMichelPLGilleryPAssociation of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetesDiabetes Metab Res Rev201430867968524449227
  • RyleCDonaghyMNon-enzymatic glycation of peripheral nerve proteins in human diabeticsJ Neurol Sci1995129162687751847
  • SugimotoKYasujimaMYagihashiSRole of advanced glycation end products in diabetic neuropathyCurr Pharm Des2008141095396118473845
  • ObrosovaIGDiabetes and the peripheral nerveBiochim Biophys Acta2009179293194019061951
  • GreeneDASimaAAStevensMJFeldmanELLattimerSAComplications: neuropathy, pathogenetic considerationsDiabetes Care19921512190219251464245
  • StavniichukRShevalyeHHirookaHNadlerJLObrosovaIGInterplay of sorbitol pathway of glucose metabolism, 12/15-lipoxygenase, and mitogen-activated protein kinases in the pathogenesis of diabetic peripheral neuropathyBiochem Pharmacol201283793294022285226
  • ChungSSMHoECLamKSChungSKContribution of polyol pathway to diabetes-induced oxidative stressJ Am Soc Nephrol2003148 Suppl 3233S236S
  • GeraldesPKingGLActivation of protein kinase C isoforms and its impact on diabetic complicationsCirc Res201010681319133120431074
  • LeppinKBehrendtAKReichardMDiabetes mellitus leads to accumulation of dendritic cells and nerve fiber damage of the subbasal nerve plexus in the corneaInvest Ophthalmol Vis Sci20145563603361524781935
  • ZieglerDPapanasNZhivovAEarly detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetesDiabetes20146372454246324574045
  • MessmerEMSchmid-TannwaldCZappDKampikAIn vivo confocal microscopy of corneal small fiber damage in diabetes mellitusGraefes Arch Clin Exp Ophthalmol201024891307131220490534
  • MisraSLCraigJPPatelDVIn vivo confocal microscopy of corneal nerves: an ocular biomarker for peripheral and cardiac autonomic neuropathy in type 1 diabetes mellitusInvest Ophthalmol Vis Sci20155695060506526241393
  • EdwardsKPritchardNVagenasDRussellAMalikRAEfronNUtility of corneal confocal microscopy for assessing mild diabetic neuropathy: baseline findings of the LANDMark studyClin Exp Optom201295334835422540156
  • DemillDLHussainMPop-BusuiRShteinRMOcular surface disease in patients with diabetic peripheral neuropathyBr J Ophthalmol2016100792492826500330
  • PritchardNEdwardsKDehghaniCLongitudinal assessment of neuropathy in type 1 diabetes using novel ophthalmic markers (LANDMark): study design and baseline characteristicsDiabetes Res Clin Pract2014104224825624629408
  • TavakoliMBegumPMcLaughlinJMalikRACorneal confocal microscopy for the diagnosis of diabetic autonomic neuropathyMuscle Nerve201552336337025556884
  • MaddaloniESabatinoFDel ToroRIn vivo corneal confocal microscopy as a novel non-invasive tool to investigate cardiac autonomic neuropathy in Type 1 diabetesDiabet Med201532226226625251450
  • EdwardsKPritchardNDehghaniCCorneal confocal microscopy best identifies the development and progression of neuropathy in patients with type 1 diabetesDiabetes20173113251327
  • JiangMSYuanYGuZXZhuangSLCorneal confocal microscopy for assessment of diabetic peripheral neuropathy: a meta-analysisBr J Ophthalmol2016100191425677672
  • NitodaEKallinikosPPallikarisACorrelation of diabetic retinopathy and corneal neuropathy using confocal microscopyCurr Eye Res2012371089890622632054
  • SzalaiEDeákEMódisLEarly corneal cellular and nerve fiber pathology in young patients with type 1 diabetes mellitus identified using corneal confocal microscopyInvest Ophthalmol Vis Sci201657385385826943147
  • BitirgenGOzkagniciAMalikRAKerimogluHCorneal nerve fibre damage precedes diabetic retinopathy in patients with type 2 diabetes mellitusDiabet Med201431443143824117485
  • MalikRAVevesATesfayeSSmall fibre neuropathy: role in the diagnosis of diabetic sensorimotor polyneuropathyDiabetes Metab Res Rev201127767868421695760
  • AlbersJWBrownMBSimaAAGreeneDANerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial: the effects of age, sex, type of diabetes, disease duration, and anthropometric factors. Tolrestat study group for the early diabetes intervention trialNeurology199646185918559426
  • QuattriniCTavakoliMJeziorskaMSurrogate markers of small fiber damage in human diabetic neuropathyDiabetes20075682148215417513704
  • TavakoliMKallinikosPIqbalACorneal confocal microscopy detects improvement in corneal nerve morphology with an improvement in risk factors for diabetic neuropathyDiabet Med201128101261126721699561
  • YorekMSObrosovAShevalyeHEffect of diet-induced obesity or type 1 or type 2 diabetes on corneal nerves and peripheral neuropathy in C57Bl/6J miceJ Peripher Nerv Syst2015201243125858759
  • SmithAGRussellJFeldmanELLifestyle intervention for pre-diabetic neuropathyDiabetes Care20062961294129916732011
  • TavakoliMMitu-PretorianMPetropoulosINCorneal confocal microscopy detects early nerve regeneration in diabetic neuropathy after simultaneous pancreas and kidney transplantationDiabetes201362125426023002037
  • HollandEJMannisMJLeeWBOcular Surface Disease: Cornea, Conjunctiva and Tear FilmLondonElsevier/Saunders2013
  • LeongYYTongLBarrier function in the ocular surface: from conventional paradigms to new opportunitiesOcul Surf201513210310925881994
  • CaiDZhuMPetrollWMKoppakaVRobertsonDMThe impact of type 1 diabetes mellitus on corneal epithelial nerve morphology and the corneal epitheliumAm J Pathol2014184102662267025102563
  • BeuermanRWSchimmelpfennigBSensory denervation of the rabbit cornea affects epithelial propertiesExp Neurol19806911962017389846
  • YinJHuangJChenCGaoNWangFYuFSCorneal complications in streptozocin-induced type I diabetic ratsInvest Ophthalmol Vis Sci20115296589659621715347
  • KimECKimDJLeeSSKimMSUltrastructural changes of cornea after ethanol ingestion in Otsuka Long-Evans Tokushima fatty (OLETF) and Long-Evans Tokushima Otsuka (LETO) ratsGraefes Arch Clin Exp Ophthalmol2010248101457146620582705
  • DiGDuXQiXMesenchymal stem cells promote diabetic corneal epithelial wound healing through TSG-6–dependent stem cell activation and macrophage switchInvest Ophthalmol Vis Sci201758104344435428810264
  • GöbbelsMSpitznasMOldendoerpJImpairment of corneal epithelial barrier function in diabeticsGraefes Arch Clin Exp Ophthalmol198922721421442721983
  • GekkaMMiyataKNagaiYCorneal epithelial barrier function in diabetic patientsCornea2004231353714701955
  • US Food and Drug Administration[homepage on the Internet] When is LASIK not for me? Available from: https://www.fda.gov/medi-caldevices/productsandmedicalprocedures/surgeryandlifesupport/lasik/ucm061366.htmAccessed April 20, 2018
  • FraunfelderFWRichLFLaser-assisted in situ keratomileusis complications in diabetes mellitusCornea200221324624811917170
  • HalkiadakisIBelfairNGimbelHVLaser in situ keratomileusis in patients with diabetesJ Cataract Refract Surg200531101895189816338557
  • Cobo-SorianoRBeltránJBavieraJLASIK outcomes in patients with underlying systemic contraindicationsOphthalmology200611371118.e11118.e816647130
  • MoshirfarMLASIK in patients with diabetes mellitus Available from: http://eyewiki.aao.org/LASIK_in_Patients_With_Diabetes_MellitusAccessed April 20, 2018
  • PershingSMorrisonDEHernandez-BoussardTCataract surgery complications and revisit rates among three statesAm J Ophthalmol201617113013827615607
  • GoebbelsMTear secretion and tear film function in insulin dependent diabeticsBr J Ophthalmol2000841192110611093
  • DogruMKaderliBGeliskenOOcular surface changes with applanation contact lens and coupling fluid use after argon laser photocoagulation in noninsulin-dependent diabetes mellitusAm J Ophthalmol2004138338138815364219
  • OnoTYukiKOzekiNShibaDTsubotaKOcular surface complications after trabeculectomy: incidence, risk factors, time course and prognosisOphthalmologica20132302939923774034
  • FribergTROhjiMSchererJJTanoYFrequency of epithelial debridement during diabetic vitrectomyAm J Ophthalmol2003135455355412654382
  • JiangDXiaoXFuTMashaghiALiuQHongJTransient tear film dysfunction after cataract surgery in diabetic patientsPLoS One2016111e014675226771186
  • FujishimaHTsubotaKImprovement of corneal fluorescein staining in post cataract surgery of diabetic patients by an oral aldose reductase inhibitor, ONO-2235Br J Ophthalmol200286886086312140204
  • AchtsidisVEleftheriadouIKozanidouEDry eye syndrome in subjects with diabetes and association with neuropathyDiabetes Care20143710e210e21125249675
  • LvHLiAZhangXMeta-analysis and review on the changes of tear function and corneal sensitivity in diabetic patientsActa Ophthalmol2014922e96e10423782539
  • MisraSLPatelDVMcGheeCNJPeripheral neuropathy and tear film dysfunction in type 1 diabetes mellitusJ Diabetes Res2014201484865925177708
  • DehghaniCPritchardNEdwardsKNatural history of corneal nerve morphology in mild neuropathy associated with type 1 diabetes: development of a potential measure of diabetic peripheral neuropathyInvest Ophthalmol Vis Sci201455127982799025406279
  • Creuzot-GarcherCLafontainePOGualinoOD’AthisPPetitJMBronAStudy of ocular surface involvement in diabetic patientsJ Fr Ophtalmol2005286583588 French16141920
  • DemillDLHussainMPop-BusuiRShteinRMOcular surface disease in patients with diabetic peripheral neuropathyBr J Ophthalmol2016100792492826500330
  • NakamuraMOfujiKChikamaTNishidaTCombined effects of substance P and insulin-like growth factor-1 on corneal epithelial wound closure of rabbit in vivoCurr Eye Res19971632752789088746
  • YamadaMOgataMKawaiMMashimaYNishidaTSubstance P in human tearsCornea2003227 SupplS48S5414703707
  • MarkoulliMYouJKimJCorneal nerve morphology and tear film substance P in diabetesOptom Vis Sci201794772673128650386
  • YamadaMOgataMKawaiMMashimaYDecreased substance P concentrations in tears from patients with corneal hypesthesiaAm J Ophthalmol2000129567167210844065
  • RochaEMCunhaDACarneiroEMBoscheroACSaadMJVellosoLAIdentification of insulin in the tear film and insulin receptor and IGF-1 receptor on the human ocular surfaceInvest Ophthalmol Vis Sci200243496396711923235
  • DingJLiuYSullivanDAEffects of insulin and high glucose on human meibomian gland epithelial cellsInvest Ophthalmol Vis Sci201556137814782026658502
  • ChenDKFrizziKEGuernseyLSLadtKMizisinAPCalcuttNARepeated monitoring of corneal nerves by confocal microscopy as an index of peripheral neuropathy in type-1 diabetic rodents and the effects of topical insulinJ Peripher Nerv Syst201318430631524147903
  • WuYCBucknerBRZhuMCavanaghHDRobertsonDMElevated IGFBP3 levels in diabetic tears: a negative regulator of IGF-1 signaling in the corneal epitheliumOcul Surf201210210010722482470
  • ZagonISKlocekMSSassaniJWMcLaughlinPJUse of topical insulin to normalize corneal epithelial healing in diabetes mellitusArch Ophthalmol200712581082108817698755
  • ZagonISSassaniJWMcLaughlinPJInsulin treatment ameliorates impaired corneal reepithelialization in diabetic ratsDiabetes20065541141114716567540
  • KlocekMSSassaniJWMcLaughlinPJZagonISNaltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type I diabetic ratsExp Eye Res200989568669219576213
  • SpoorTCHartelWCWynnPSpoorDKComplications of continuous-wear soft contact lenses in a nonreferral populationArch Ophthalmol19841029131213136591900
  • O’DonnellCEfronNCorneal hydration control in contact lens wearers with diabetes mellitusOptom Vis Sci2006831222616432469
  • O’DonnellCEfronNBoultonAJA prospective study of contact lens wear in diabetes mellitusOphthalmic Physiol Opt200121212713811261347
  • HanSBYangHKHyonJYWeeWRAssociation of dry eye disease with psychiatric or neurological disorders in elderly patientsClin Interv Aging20171278579228553087
  • GoyalSHamrahPUnderstanding neuropathic corneal pain – gaps and current therapeutic approachesSemin Ophthalmol2016311–2597026959131
  • SchulzeSDSekundoWKrollPAutologous serum for the treatment of corneal epithelial abrasions in diabetic patients undergoing vitrectomyAm J Ophthalmol2006142220721116876497
  • ThaiLCTomlinsonARidderWHContact lens drying and visual performance: the vision cycle with contact lensesOptom Vis Sci200279638138812086305
  • WangCPengYPanSLiLEffect of insulin-like growth factor-1 on corneal surface ultrastructure and nerve regeneration of rabbit eyes after laser in situ keratomileusisNeurosci Lett201455816917424211688
  • ChikamotoNChikamaTYamadaNNishidaTIshimitsuTKamiyaAEfficacy of substance P and insulin-like growth factor-1 peptides for preventing postsurgical superficial punctate keratopathy in diabetic patientsJpn J Ophthalmol200953546446919847599
  • PriyadarsiniSRowseyTGMaJXKaramichosDUnravelling the stromal-nerve interactions in the human diabetic corneaExp Eye Res2017164223028827027
  • LambiaseARamaPBoniniSCaprioglioGAloeLTopical treatment with nerve growth factor for corneal neurotrophic ulcersN Engl J Med199833817117411809554857
  • ParkJHKangS-SKimJYTchahHNerve growth factor attenuates apoptosis and inflammation in the diabetic corneaInvest Ophthalmol Vis Sci201657156767677527978558
  • KimSYChoiJSJooCKEffects of nicergoline on corneal epithelial wound healing in rat eyesInvest Ophthalmol Vis Sci200950262162518836171
  • NakaharaMMiyataKOtaniSA randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patientsBr J Ophthalmol200589326626815722300
  • ZagonISSassaniJWMcLaughlinPJReepithelialization of the human cornea is regulated by endogenous opioidsInvest Ophthalmol Vis Sci2000411738110634604
  • ZagonISKlocekMSSassaniJWMcLaughlinPJDry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitusArch Ophthalmol2009127111468147319901212
  • ZagonISSassaniJWImmonenJAMcLaughlinPJOcular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexoneClin Exp Ophthalmol201442215916823777539
  • HampelUKrügerMKunnenCGarreisFWillcoxMPaulsenFIn vitro effects of docosahexaenoic and eicosapentaenoic acid on human meibomian gland epithelial cellsExp Eye Res201514013914826335632
  • ErdinestNOvadiaHKormasRSolomonAAnti-inflammatory effects of resolvin-D1 on human corneal epithelial cells: in vitro studyJ Inflamm20141116
  • ShevalyeHYorekMSCoppeyLJEffect of enriching the diet with menhaden oil or daily treatment with resolvin D1 on neuropathy in a mouse model of type 2 diabetesJ Neurophysiol2015114119920825925322
  • Abdul-HamidMMoustafaNAmelioration of alloxan-induced diabetic keratopathy by beta-caroteneExp Toxicol Pathol2014661495924129090